Neurocrine Biosciences
Latest round
- Series A
Last raised
- Jun 1992
Total raised
- $3.5M
Investors
- 4
About Neurocrine Biosciences
Founded in 1992, Neurocrine Biosciences, Inc. focuses on discovering and developing innovative treatments for neurological, neuroendocrine, and neuropsychiatric disorders, providing critical therapeutic options for patients in need. Neurocrine Biosciences specializes in creating treatments for neurological disorders and was founded in San Diego, US. The CEO of the company is Kevin Gorman. Neurocrine Biosciences, Inc. specializes in the discovery and development of innovative treatments for patients with neurological, neuroendocrine, and neuropsychiatric disorders. The company’s core product offerings include therapeutics aimed at addressing conditions such as movement disorders and endocrine-related diseases. These treatments are designed to alleviate suffering for patients who currently lack viable therapeutic options, thus fulfilling a critical need in the healthcare landscape. Neurocrine's solutions serve a diverse clientele that includes healthcare providers, hospitals, and specialty pharmacies, directly impacting end users who seek relief from debilitating conditions.Neurocrine Biosciences generates revenue through the commercialization of its pharmaceutical products, which are sold primarily through direct-to-consumer channels and partnerships with healthcare providers.60 mn. The transaction structure typically involves agreements with hospitals and pharmacies that facilitate the distribution of their therapeutics. Revenue is derived from the sale of flagship products that cater to specific disorders such as tardive dyskinesia. The company’s revenue model is bolstered by ongoing collaborations and potential licensing agreements that enhance its market reach and therapeutic offerings, reinforcing its commitment to addressing significant health needs in the communities it serves.
Who invested in Neurocrine Biosciences
4 investors across 1 round
See all investors in Neurocrine Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 1992
Amount
$3.5M
Investors
Questions about Neurocrine Biosciences
Who invested in Neurocrine Biosciences?
Neurocrine Biosciences has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurocrine Biosciences raised?
Neurocrine Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neurocrine Biosciences last raise money?
Neurocrine Biosciences's most recent round on record is a Series A, in Jun 1992.
What does Neurocrine Biosciences do?
Founded in 1992, Neurocrine Biosciences, Inc.
Where is Neurocrine Biosciences headquartered?
Neurocrine Biosciences is headquartered in San Diego, US.
Which VCs invest in companies like Neurocrine Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Neurocrine Biosciences's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Neurocrine Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.